NPI registry status
Active
2026 NPPES data Neurological Surgery Physician NPI 1174523872 MDPA
Verify on CMS → Peyman Pakzaban, MDPA
Neurological Surgery Physician in Pasadena, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,116 in Neurological Surgery Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
299
Medicare Part D claims · 181 beneficiaries · Neurological Surgery Physician avg: 181
MIPS score
100/100
▲ 17 pts above national avg 83.1 · Exceptional
Industry payments
$30.3K
3 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Peyman Pakzaban, MDPA reported a CMS MIPS final score of 100/100 - above the 83.1 national average - and filed 299 Medicare Part D claims in 2023.
- 100/100
- MIPS score · +17 vs avg
- 299
- Part D claims, 2023
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Peyman Pakzaban, MDPA's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
100 Top 7% higher than 93% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Peyman Pakzaban, MDPA sits
This provider among neurological surgery physician peers
Across the 1,737 neurological surgery physician providers who report both Medicare Part D prescribing and a MIPS quality score, Peyman Pakzaban, MDPA writes more Part D claims than 82% of them and scores higher on MIPS quality than 92% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one neurological surgery physician peer from a representative sample of 60; the gold marker is Peyman Pakzaban, MDPA. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Peyman Pakzaban, MDPA practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Peyman Pakzaban, MDPA?
High performer (top quartile)Primary specialty
Neurological Surgery Physician
Medicare Part D claims
299 65% vs specialty avg
MIPS final score
100/100 16.9 pts vs avg
Specialty distribution in Texas
How Neurological Surgery Physician compares to other specialties among Texas providers
Medicare quality performance, MIPS
Peyman Pakzaban, MDPA's 2023 MIPS final score plotted against the Neurological Surgery Physician national average
- MIPS Final Score
- 100/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Neurological Surgery Physician) - 100/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Peyman Pakzaban, MDPA appears in the CMS NPPES registry as a Neurological Surgery Physician provider holding MDPA credentials at 3801 VISTA RD STE 440, Pasadena, TX, 77504, with a listed phone of (713) 941-0008. NPI 1174523872 was issued on 07/26/2005.
Medicare Part D records for calendar year 2023 show 299 prescription claims written by this provider, covering 181 Medicare beneficiaries and totaling roughly $3K in drug spend, with an opioid prescribing rate of 71.2%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 100), compared with the national average of 83.1.
Neurological Surgery Physician is a mid-sized specialty nationwide, with 8,116 enrolled providers across 53 states and an average of 181 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1174523872 |
|---|---|
| Specialty | Neurological Surgery Physician |
| Credentials | MDPA |
| Gender | Male |
| NPI Issued | 07/26/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
100
Final Score
Avg: 83.1
100
Quality
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Peyman Pakzaban, MDPA. Source: openpaymentsdata.cms.gov.
Total received
$30.3K
Largest payer
DePuy Synthes Products, Inc.
Most common payment type
Royalty or License
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Peyman Pakzaban, MDPA. To verify Peyman Pakzaban, MDPA's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
299
Total Claims
$3K
Total Drug Cost
181
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 301
- Total Day Supply
- 2,967
- Generic Drug Cost
- $3K
- Opioid Claims
- 213 (71.2% rate)
- Antibiotic Claims
- 11
Patient Demographics
- Average Patient Age
- 72.1 years
- Avg HCC Risk Score
- 1.22
- Gender Split
- 52% female / 48% male
- Age Distribution
- <65: 14, 65-74: 103, 75-84: 52, 85+: 12
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Peyman Pakzaban, MDPA prescribes most
Top Medicare Part D drugs by claim count, 2023
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
168 claims
- Tramadol Hcl 29
Tramadol Hcl
29 claims
- Methylprednisolone 26
Methylprednisolone
26 claims
- Gabapentin 15
Gabapentin
15 claims
- Acetaminophen-Code… 11
Acetaminophen-Codeine
11 claims
- Levetiracetam 11
Levetiracetam
11 claims
| Drug | Claims |
|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 168 |
| Tramadol Hcl | 29 |
| Methylprednisolone | 26 |
| Gabapentin | 15 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 11 |
| Levetiracetam | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Neurological Surgery Physician Overview
How Peyman Pakzaban, MDPA fits within the Neurological Surgery Physician landscape nationally.
8,116
Neurological Surgery Physician Providers in US
53
States with Neurological Surgery Physician
181
Avg Claims per Provider
Peyman Pakzaban, MDPA's 299 claims are above the specialty average of 181.
Nearby Neurological Surgery Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Pakzaban.
Dr. Gareth Adams
MD
The Woodlands, TX
Dr. Dare Adewumi
M.D.
Fort Worth, TX
Dr. Osama Ahmed
MD
Live Oak, TX
Dr. Nicholas Ahye
M.D.
Houston, TX
Dr. Olaide Ajayi
MD
Fort Worth, TX
Compare Neurological Surgery Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Neurological Surgery Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Texas
Frequently Asked Questions
What is Peyman Pakzaban, MDPA's specialty? ▼
Peyman Pakzaban, MDPA specializes in Neurological Surgery Physician and practices in Pasadena, Texas. Credentials: MDPA.
How much does Peyman Pakzaban, MDPA prescribe under Medicare Part D? ▼
In 2023, Peyman Pakzaban, MDPA wrote 299 Medicare Part D claims totaling $3K in drug costs for 181 beneficiaries.
What is Peyman Pakzaban, MDPA's Medicare quality score? ▼
Peyman Pakzaban, MDPA has a CMS MIPS Final Score of 100/100 (Quality: 100). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Peyman Pakzaban, MDPA located? ▼
Peyman Pakzaban, MDPA is located at 3801 VISTA RD STE 440, Pasadena, TX, 77504. Phone: (713) 941-0008.
What is Peyman Pakzaban, MDPA's NPI number? ▼
Peyman Pakzaban, MDPA's National Provider Identifier (NPI) is 1174523872, issued on 07/26/2005.
Does Peyman Pakzaban, MDPA prescribe opioids? ▼
Yes, Peyman Pakzaban, MDPA had 213 opioid claims in 2023 with an opioid prescribing rate of 71.2%.
How many Neurological Surgery Physician providers are there in the US? ▼
There are 8,116 Neurological Surgery Physician providers across 53 states in the US. The average Neurological Surgery Physician provider writes 181 Medicare Part D claims per year.
What drugs does Peyman Pakzaban, MDPA prescribe most often? ▼
Based on 2023 Medicare Part D data, Peyman Pakzaban, MDPA's most frequently prescribed drugs include Hydrocodone-Acetaminophen, Tramadol Hcl, Methylprednisolone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Peyman Pakzaban, MDPA accept Medicare? ▼
Peyman Pakzaban, MDPA appears in CMS Medicare data with 299 Part D claims and 181 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Peyman Pakzaban, MDPA's credentials? ▼
Peyman Pakzaban, MDPA's NPI is 1174523872 with credentials MDPA. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.